PROPANC BIOPHARMA, INC. Interest Expense on Debt
PROPANC BIOPHARMA, INC. (PPCB) had Interest Expense on Debt of $4.80 thousand as of 2026-02-12, per its S-1 filed 2026-07-17.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-07-17
- PROPANC BIOPHARMA, INC. interest expense, debt for the quarter ending 2015-06-30 was $0.00.
- PROPANC BIOPHARMA, INC. interest expense, debt for the quarter ending 2015-03-31 was $0.00.
- PROPANC BIOPHARMA, INC. interest expense, debt for the quarter ending 2014-12-31 was $0.00.
- PROPANC BIOPHARMA, INC. interest expense, debt for the quarter ending 2014-09-30 was $405.00K.
- PROPANC BIOPHARMA, INC. interest expense, debt for fiscal 2016 was $405.00K, a 0.00% change from fiscal 2015.
- PROPANC BIOPHARMA, INC. interest expense, debt for fiscal 2015 was $405.00K.
| Period end | Interest Expense, Debt | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|---|
| 2026-02-12 | $4.80K S-1 · filed 2026-07-17 | ||||
| 2025-08-19 | $653.00 S-1 · filed 2026-07-17 | ||||
| 2016-06-30 | $405.00K 10-K · filed 2016-09-28 | ||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-30 | $0.00 derived: sum of 2 quarters · filed 2015-09-30 | $0.00 derived: sum of 3 quarters · filed 2015-09-30 | $405.00K 10-K · filed 2015-09-30 | |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | $0.00 derived: sum of 2 quarters · filed 2015-05-15 | $405.00K 10-Q · filed 2015-05-15 | ||
| 2014-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | $405.00K 10-Q · filed 2015-02-17 | |||
| 2014-09-30 | $405.00K 10-Q · filed 2014-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |